[Maeil Business Newspaper] Vaxdigm selected for the Ministry of SMEs and Startups' 2026 'Deep Tech Track'

2026-05-20

Bio company Vaxdigm (VAXDIGM) announced on the 20th that it has been finally selected as a company to carry out a project under 'Deep Tech TIPS', the Ministry of SMEs and Startups' programme for fostering advanced technology startups. [Vaxdigm]

Selected on the recommendation of New Paradigm Investment, an early-stage specialist investment firm, Vaxdigm will secure a total of KRW 1.5 billion in government research and development (R&D) funding over the next three years. Vaxdigm plans to concentrate these funds on advancing its 'ChaperNova' system, a patented microorganism-based protein production platform. The plan is to use a mechanism that induces the proper folding of proteins at the RNA level to resolve the yield-reduction problem that has been a weakness of existing bio manufacturing processes, and to establish early on a mass-production scale-up system with maximised cost competitiveness.

The company will also follow a phased commercialisation roadmap to establish itself in the early market. Its strategy is first to open up B2B channels — including research use only (RUO) products as well as the supply of cosmetics, medical device and pharmaceutical raw materials — to generate stable cash flow. It then intends to leverage its verified process scalability to drive large-scale licensing-out and joint development results with global pharmaceutical companies in earnest.

Kim Sung-jae, CEO of Vaxdigm, said, "With substantial government support behind us, we will fully prove the economic viability of our technology supply," adding, "We will quickly establish ourselves as an irreplaceable core process partner in the global bio supply chain market."

Source: https://www.mk.co.kr/news/it/12052885